Da-Yong Lu, Ting Ren Lu and Shan Cao
A major obstacle to control cancer growth and metastases in patients is the widespread inappropriate use of anticancer drugs. Individualized cancer chemotherapy (ICC) has been attracting increasing attentions in medical circle and will continue to show beneficial outcome in the future. This review addresses this issue by discussing one specific strategy of ICC, biomarker-oriented therapy. Many longstanding key debates and future trends are discussed.
Teile diesen Artikel
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi 